| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.36 | 2e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.32 | 1e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-05 |